Department Of Neurology 2
51. Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021
52. Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021
53. Iron deficiency in obesity and after bariatric surgery
54. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
55. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
56. Forecasting the effects of smoking prevalence scenarios on years of life lost and life expectancy from 2022 to 2050: a systematic analysis for the Global Burden of Disease Study 2021
57. The epidemiology of myasthenia gravis
58. The epidemiology of myasthenia gravis
59. Estimates, trends, and drivers of the global burden of type 2 diabetes attributable to PM2·5 air pollution, 1990–2019: an analysis of data from the Global Burden of Disease Study 2019
60. Estimates, trends, and drivers of the global burden of type 2 diabetes attributable to PM2·5 air pollution, 1990–2019: an analysis of data from the Global Burden of Disease Study 2019
61. Estimates, trends, and drivers of the global burden of type 2 diabetes attributable to PM2·5 air pollution, 1990–2019: an analysis of data from the Global Burden of Disease Study 2019
62. Global, regional, and national burden of HIV/AIDS, 1990–2021, and forecasts to 2050, for 204 countries and territories: the Global Burden of Disease Study 2021
63. Burden of infectious disease studies in Europe and the United Kingdom: a review of methodological design choices
64. Global, regional, and national stillbirths at 20 weeks gestation or longer in 204 countries and territories, 1990–2021: findings from the Global Burden of Disease Study 2021
65. Neuro-Cells Mitigate Amyloid Plaque Formation and Behavioral Deficits in the APPswe/PS1dE9 Model of Alzheimer Disease While Also Reducing IL-6 Production in Human Monocytes
66. Therapeutic Effects of Neuro-Cells on Amyloid Pathology, BDNF Levels, and Insulin Signalling in APPswe/PSd1E9 Mice
67. Analyzing central-line associated bloodstream infection prevention bundles in 22 countries: The results of ID-IRI survey
68. The effects of vitamin D and calcium on primary dysmenorrhea: a systematic review
69. The impact of primary dysmenorrhea on adolescents’ activities and school attendance
70. The relation between vitamin D and the adolescents’ mid-luteal estradiol and progesterone
71. The relationship between vitamin D and adolescents’ parathyroid hormone and bone mineral density
72. Vitamin D and vitamin D receptor polymorphism in Asian adolescents with primary dysmenorrhea
73. BRAT1–related disorders: phenotypic spectrum and phenotype-genotype correlations from 97 patients
74. BRAT1–related disorders: phenotypic spectrum and phenotype-genotype correlations from 97 patients
75. BRAT1–related disorders: phenotypic spectrum and phenotype-genotype correlations from 97 patients
76. BRAT1–related disorders: phenotypic spectrum and phenotype-genotype correlations from 97 patients
77. Classical fever of unknown origin in 21 countries with different economic development: an international ID-IRI study
78. Managing adult patients with infectious diseases in emergency departments: international ID-IRI study
79. Comparative clinical study of the effectiveness of translingual neurostimulation in patients with post-stroke cognitive impairment.
80. Comparative clinical study of the effectiveness of translingual neurostimulation in patients with post-stroke cognitive impairment.
81. Comparative clinical study of the effectiveness of translingual neurostimulation in patients with post-stroke cognitive impairment.
82. Sarcopenia in rheumatic and musculoskeletal diseases: pathophysiology, diagnosis, and management
83. Global, regional, and national burden of epilepsy, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
84. Global, regional, and national burden of epilepsy, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
85. Global, regional, and national burden of epilepsy, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
86. Global, regional, and national burden of epilepsy, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
87. Global, regional, and national burden of epilepsy, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
88. Global, regional, and national burden of epilepsy, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
89. Global, regional, and national burden of epilepsy, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
90. Global, regional, and national burden of stroke and its risk factors, 1990-2019: A systematic analysis for the Global Burden of Disease Study 2019
91. Global, regional, and national burden of stroke and its risk factors, 1990-2019: A systematic analysis for the Global Burden of Disease Study 2019
92. Global, regional, and national burden of stroke and its risk factors, 1990-2019: A systematic analysis for the Global Burden of Disease Study 2019
93. Global, regional, and national burden of stroke and its risk factors, 1990-2019: A systematic analysis for the Global Burden of Disease Study 2019
94. Global, regional, and national burden of stroke and its risk factors, 1990-2019: A systematic analysis for the Global Burden of Disease Study 2019
95. Global, regional, and national burden of stroke and its risk factors, 1990-2019: A systematic analysis for the Global Burden of Disease Study 2019
96. Global, regional, and national burden of stroke and its risk factors, 1990-2019: A systematic analysis for the Global Burden of Disease Study 2019
97. Global, regional, and national burden of stroke and its risk factors, 1990-2019: A systematic analysis for the Global Burden of Disease Study 2019
98. Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
99. Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
100. Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
1 2 3 4 13